Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

BPC-157 (5mg)

Description Body Protective Compound 157 (BPC-157) represents a synthetic pentadecapeptide originally isolated from human gastric juice and subsequently developed for research applications. The compound exhibits the molecular formula C62H98N16O22 with a molecular weight of 1419.5 g/mol and is catalogued in PubChem under CID 9941957. The peptide sequence consists of fifteen amino acids arranged as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, forming a stable molecular structure that demonstrates resistance to enzymatic degradation compared to other peptide compounds. The chemical stability of BPC-157 is attributed to its unique amino acid composition and sequence arrangement, which allows the peptide to maintain biological activity under various laboratory conditions. Current research status indicates that BPC-157 is under investigation in clinical trial NCT02637284, designated as PCO-02, which focuses on safety and pharmacokinetic evaluation. For research use only. Only

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Description

Body Protective Compound 157 (BPC-157) represents a synthetic pentadecapeptide originally isolated from human gastric juice and subsequently developed for research applications. The compound exhibits the molecular formula C62H98N16O22 with a molecular weight of 1419.5 g/mol and is catalogued in PubChem under CID 9941957. The peptide sequence consists of fifteen amino acids arranged as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, forming a stable molecular structure that demonstrates resistance to enzymatic degradation compared to other peptide compounds. The chemical stability of BPC-157 is attributed to its unique amino acid composition and sequence arrangement, which allows the peptide to maintain biological activity under various laboratory conditions. Current research status indicates that BPC-157 is under investigation in clinical trial NCT02637284, designated as PCO-02, which focuses on safety and pharmacokinetic evaluation. For research use only.

Only logged in customers who have purchased this product may leave a review.

Connected topics

Follow this recovery question